Response of tumour necrosis factor-α to delayed in vitro monocyte stimulation in patients with septic shock is related to outcome

Clinical Science

Volumn 102, Issue 3, 2002, Pages 315-320

  Appoloni, Olivier ^a   Vincent, Jean Louis ^a   Duchateau, Jean ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

Cytokine production; In vitro stimulation; Monocytes; Outcome; Septic shock; Tumour necrosis factor

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CLINICAL ARTICLE; DISEASE COURSE; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOSTIMULATION; MALE; MONOCYTE; PRIORITY JOURNAL; SEPTIC SHOCK; SURVIVAL;

AGED; CELLS, CULTURED; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; INTERLEUKIN-1; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; MONOCYTES; POKEWEED MITOGENS; PROSPECTIVE STUDIES; SHOCK, SEPTIC; STATISTICS, NONPARAMETRIC; STIMULATION, CHEMICAL; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036188871     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20010260     Document Type: Article

References (25)

1. Has mortality of septic shock changed with time?
2. Current understanding of sepsis
3. Treating patients with severe sepsis
4. Shock and tissue injury induced by recombinant human cachectin
5. Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock
6. Association of TNF2, a TNFα promoter polymorphism, with septic shock susceptibility and mortality
7. Tumor necrosis factor gene polymorphism and septic shock in surgical infection
8. Association of the tumor necrosis factor-2 allele, a polymorphism of the tumor necrosis factor-α promoter, with plasma tumor necrosis factor-α levels and mortality from septic shock
9. A Taq 1 polymorphism in the human IL-1β gene correlates with IL-1β secretion in vitro
10. IL-1β, IL-1ra, IL-4, and IL-10 gene polymorphisms: Relationship to occurrence and severity of rheumatoid arthritis
11. The combination of polymorphisms within IFN-γ receptor 1 and receptor 2 associated with the risk of systemic lupus erythematosus
12. Un polymorphisme du recepteur aux bactéries gram negatif peut prédisposer au choc septique
13. Association between the C-159T genetic polymorphism of the CD14 gene and septic shock susceptibility and mortality
14. Monocyte deactivation - Rationale for a new therapeutic strategy in sepsis
15. Genetic influence on cytokine production and fatal meningococcal disease
16. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis
17. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study
18. Use of the SOFA to assess the incidence of organ dysfunction/failure in intensive care units: Results of a multicenter, prospective study
19. Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood. Comparison with isolated PBMC stimulation
20. Dysregulation of in vitro cytokine production by monocytes during sepsis
21. Reduced ex vivo interleukin-8 production by neutrophils in septic and non septic systemic inflammatory response syndrome
22. Signals involved in IL-1 synthesis and release by LPS-stimulated monocytes/macrophages
23. Modulation of the endotoxin receptor (CD14) in septic patients
24. Endotoxin-stimulated human monocyte secretion of IL-1, TNFα and PGE2 shows stable interindividual differences
25. Heritable major histocompatibility complex class II-associated differences in production of TNFα: Relevance to genetic predisposition to systemic lupus erythematosus